全基因組亞硫酸氫鹽定序市場規模、佔有率和成長分析：按產品/服務、應用、最終用戶、技術和地區分類－2026-2033年產業預測

2024 年全球全基因組亞硫酸氫鹽定序市場價值為 15.8 億美元，預計到 2025 年將成長至 18.1 億美元，到 2033 年將成長至 54.8 億美元，在預測期（2026-2033 年）內複合年成長率為 14.8%。

全球全基因組亞硫酸氫鹽定序(WGBS) 市場的特點是供應商眾多，他們提供試劑、樣品製備試劑盒、定序平台和生物資訊服務，從而實現全基因組 DNA 甲基化圖譜的繪製。這項技術對於理解與多種疾病（包括癌症和神經退化性疾病）相關的表觀遺傳學改變至關重要。傳統上，由於成本高且操作複雜，WGBS 的應用僅限於學術領域，但技術的進步使其應用範圍更加廣泛，使得製藥公司和臨床研究團隊能夠將 WGBS 應用於生物標記發現。甲基化譜有助於患者分層和藥物研發，而對個人化癌症治療日益成長的需求進一步推動了市場成長，刺激了對具成本效益 WGBS 解決方案的投資，並使其應用範圍從傳統研究擴展到精準醫療領域。

全球全基因組亞硫酸氫定序市場的成長要素

全球全基因組亞硫酸氫定序市場的主要促進因素之一是癌症和其他遺傳疾病的日益普遍。隨著研究人員和臨床醫生致力於揭示導致這些疾病的表觀遺傳學改變，對全基因組亞硫酸氫鹽定序等先進定序技術的需求激增。該技術能夠對DNA甲基化模式進行全面分析，從而更深入地了解基因表現調控和潛在的治療標靶。此外，隨著個人化醫療（根據個人基因譜客製化治療方案）的日益普及，對能夠幫助識別表觀遺傳修飾的可靠定序方法的需求也進一步成長。

全球全基因組亞硫酸氫定序市場的限制因素

全球全基因組亞硫酸氫定序市場的主要限制因素是定序技術和分析的高成本。由於其複雜性，全基因組亞硫酸氫鹽定序需要先進的設備和專業人員，因此需要對實驗室基礎設施和培訓進行大量投資。此外，解讀結果所需的大規模數據分析也增加了整體成本。這種經濟負擔限制了小規模實驗室和研究機構對其應用，可能阻礙該技術的普及和市場成長。因此，許多潛在用戶可能會對在其研究和臨床應用中採用亞硫酸氫定序猶豫不決。

全球全基因組亞硫酸氫定序市場趨勢

受表觀遺傳療法日益成長的關注，全球整體全基因組亞硫酸氫鹽定序市場正經歷顯著成長。隨著製藥公司尋求利用全基因組亞硫酸氫定序來繪製疾病特異性表觀遺傳特徵圖譜，對全面甲基化譜分析的需求激增。這一趨勢促進了與專業服務供應商的合作，增強了合約研究能力，並推動了對自動化和樣本製備工作流程的投資。因此，圍繞定序平台的商業生態系統正在擴展，重點關注長期臨床應用和精準醫療計劃。在此背景下，全基因組亞硫酸氫鹽定序對於推進表觀遺傳學研究和治療開發至關重要。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球全基因組亞硫酸氫鹽定序市場規模：依產品/服務分類。

• 試劑盒和試劑
• 裝置
• 定序服務
• 生物資訊軟體

全球全基因組亞硫酸氫鹽定序市場規模：依應用領域分類

• 癌症研究
• 表觀遺傳學研究
• 發育生物學
• 精準醫療
• 農業與植物性因體學

全球全基因組亞硫酸氫鹽定序市場規模：依最終用戶分類

• 學術研究機構
• 製藥和生物技術公司
• 臨床實驗室
• 受託研究機構

全球全基因組亞硫酸氫鹽定序市場規模：依技術分類

• 短讀定序
• 長讀長定定序

全球全基因組亞硫酸氫鹽定序市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Illumina, Inc.
• Pacific Biosciences of California, Inc.
• QIAGEN NV
• F. Hoffmann-La Roche Ltd
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc.
• Revvity, Inc.
• Merck KGaA
• Takara Bio Inc.
• New England Biolabs, Inc.
• Danaher Corporation
• Oxford Nanopore Technologies plc
• BGI Genomics Co., Ltd.
• Integrated DNA Technologies, Inc.
• Zymo Research Corporation
• Tecan Group Ltd.
• Azenta, Inc.
• Eurofins Scientific SE
• Novogene Co., Ltd.
• Bio-Rad Laboratories, Inc.

結論與建議

Global Whole Genome Bisulfite Sequencing Market size was valued at USD 1.58 Billion in 2024 and is poised to grow from USD 1.81 Billion in 2025 to USD 5.48 Billion by 2033, growing at a CAGR of 14.8% during the forecast period (2026-2033).

The Global Whole Genome Bisulfite Sequencing (WGBS) market is characterized by a diverse range of suppliers providing reagents, library preparation kits, sequencing platforms, and bioinformatics services that facilitate DNA methylation mapping across genomes. This capability is crucial for understanding epigenetic alterations linked to various diseases, including cancer and neurodegeneration. Historically, WGBS was limited to academic settings due to high costs and complexity, but advancements in technology have democratized access, enabling pharmaceutical companies and clinical research groups to incorporate WGBS into biomarker discovery. The rising demand for personalized oncology therapies further propels market growth, as methylation profiles aid patient stratification and drug development, fostering investments in cost-effective WGBS solutions and expanding beyond traditional research applications into precision medicine.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Whole Genome Bisulfite Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Whole Genome Bisulfite Sequencing Market Segments Analysis

Global whole genome bisulfite sequencing market is segmented by product & service, application, end user, technology and region. Based on product & service, the market is segmented into Kits & Reagents, Instruments, Sequencing Services and Bioinformatics Software. Based on application, the market is segmented into Cancer Research, Epigenetics Research, Developmental Biology, Precision Medicine and Agricultural & Plant Genomics. Based on end user, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Clinical Laboratories and Contract Research Organizations. Based on technology, the market is segmented into Short-Read Sequencing and Long-Read Sequencing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Whole Genome Bisulfite Sequencing Market

One of the key market drivers for the global whole genome bisulfite sequencing market is the increasing prevalence of cancer and other genetic disorders. As researchers and clinicians seek to understand the epigenetic alterations that drive these conditions, demand for advanced sequencing technologies like whole genome bisulfite sequencing has surged. This technique allows for comprehensive analysis of DNA methylation patterns, enabling better insights into gene regulation and potential therapeutic targets. Furthermore, the growing focus on personalized medicine, where treatments are tailored based on individual genetic profiles, further propels the need for robust sequencing methods that aid in the identification of epigenetic modifications.

Restraints in the Global Whole Genome Bisulfite Sequencing Market

A key market restraint for the Global Whole Genome Bisulfite Sequencing Market is the high costs associated with sequencing technologies and analysis. The complex nature of whole genome bisulfite sequencing requires sophisticated equipment and specialized personnel, leading to substantial investments in laboratory infrastructure and training. Additionally, the extensive data analysis required to interpret the results adds to the overall expenditure. This financial burden can limit access for smaller laboratories and research institutions, thereby hindering broader adoption and market growth. As a result, many potential users may be deterred from incorporating bisulfite sequencing into their research and clinical applications.

Market Trends of the Global Whole Genome Bisulfite Sequencing Market

The Global Whole Genome Bisulfite Sequencing market is witnessing significant growth, fueled by an increased focus on epigenetic therapeutics. Demand for comprehensive methylation profiling has surged, as pharmaceutical companies seek to leverage whole genome bisulfite sequencing for mapping disease-specific epigenetic signatures. This trend has catalyzed collaborations with specialized service providers, enhancing contract research capabilities and promoting investments in automation and sample preparation workflows. Consequently, the commercial ecosystem surrounding sequencing platforms is expanding, aimed at long-term clinical applications and precision health initiatives. As a result, whole genome bisulfite sequencing is becoming indispensable for advancing epigenetic research and therapeutic development.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Whole Genome Bisulfite Sequencing Market Size by Product & Service & CAGR (2026-2033)

• Market Overview
• Kits & Reagents
• Instruments
• Sequencing Services
• Bioinformatics Software

Global Whole Genome Bisulfite Sequencing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cancer Research
• Epigenetics Research
• Developmental Biology
• Precision Medicine
• Agricultural & Plant Genomics

Global Whole Genome Bisulfite Sequencing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Clinical Laboratories
• Contract Research Organizations

Global Whole Genome Bisulfite Sequencing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Short-Read Sequencing
• Long-Read Sequencing

Global Whole Genome Bisulfite Sequencing Market Size & CAGR (2026-2033)

• North America (Product & Service, Application, End User, Technology)
  • US
  • Canada
• Europe (Product & Service, Application, End User, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Application, End User, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Application, End User, Technology)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Application, End User, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zymo Research Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations